Living + May/June 2008 - Issue 54

02 THINK + Opinion & Editorial. Unacceptable. 40 percent of people dying of AIDS have never received treatment. 03 REALITY BITES News from home & around the world. The Dangers of eHealth. Study Reaffirms that HIV Replication is Harmful. Over Two Million Children Worldwide with HIV/AIDS. Renewed Calls for In-Prison Needle Exchange Program. Street Kids Using Crystal Meth at "Alarming" Rate. New HIV/AIDS Vaccine Phase 1 Trial Begins. Tenofovir May Suppresses HIV in Semen, Say Study. Menopause and CAM Study. 05 FIGHTING WORDS Not All Fun and Games. The Poverty Olympics Drew Attention to the BC Government's Failure to Focus on Important Social Issues. 06 ACCOLAIDS Awards gala honours outstanding achievements in the BC AIDS movement. 08 THE POSITIVE GATHERING Sharing and Learning. A report on the third Positive Gathering, which took place at the end of March. The theme was living positively in an HIV-negative world. 09 UNTESTED, UNDIAGNOSED, UNTREATED If prospects are so much better, why is HIV diagnosis in BC getting worse? Different population groups require targeted strategies. Women. Prisoners. Rural Communities. Men who have sex with men. Youth. 14 THE BURMA STORIES Part three in a series of personal accounts of PWAs in Southeast Asia. A former doctor in Burma recorded the experiences of PWAs in Burma and illegal migrant workers in Thailand. Here's another one of their stories. 15 PREVENTION Kiss and Tell. The legalities of disclosure in intimate relationships. What the future holds. Avoiding prosecution. 17 TREATMENT INFORMATION There are dangerous strains of tuberculosis that are resistant to antibiotics. New Viral Load Test in BC. Yeast of Burden: Candidiasis is one of the most common opportunistic infections among PWAs. 20 NEW GENERATION OF AIDS DRUGS Keeping One Step Ahead. An overview of current AIDS drugs and new drugs on the horizon for treatment-experienced patients. Enfuvirtide was first on the market. Maraviroc is unique in targeting human proteins. Raltegravir is the first integrase inhibitor. Reformulating existing drugs. The new generation of protease inhibitors. Rilpivirine is a promising new nuke. 24 SIDE EFFECTS The Bare Bones. Osteoporosis and osteopenia continue to be a problem